Stock 6833 SINCO PHARMACEUTICALS HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Sinco Pharmaceuticals Holdings Limited

Equities

6833

KYG8154Y1052

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:25 30/05/2024 pm IST 		5-day change 1st Jan Change
0.233 HKD +0.87% Intraday chart for Sinco Pharmaceuticals Holdings Limited -4.90% -2.92%
26/03 Sinco Pharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
26/03 Sinco Pharmaceuticals Holdings Limited Resignation of Li Kin Wai as Joint Company Secretary and Appointment of Peng Yunlu as Executive Director CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Sinco Pharmaceuticals Holdings Limited Approves Dividend for the Year Ended 31 December 2023
CI
Sinco Pharmaceuticals' 2023 Profit Declines on Higher Tax Payments
MT
Sinco Pharmaceuticals Holdings Limited Proposes Final Cash Dividend for the Year Ended 31 December 2023, Payable on 04 June 2024
CI
Sinco Pharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Sinco Pharmaceuticals Holdings Limited Resignation of Li Kin Wai as Joint Company Secretary and Appointment of Peng Yunlu as Executive Director
CI
Sinco Pharmaceuticals Warns of Lower 2023 Profit
MT
Sinco Pharmaceuticals Holdings Limited Provides Consolidated Earning Guidance for the Year Ended 31 December 2023
CI
Sinco Pharmaceuticals Holdings Limited(SEHK:6833) dropped from S&P Global BMI Index
CI
Sinco Pharmaceuticals Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Sinco Pharmaceuticals Warns of 68% Drop in H1 Profit
MT
Sinco Pharmaceuticals Holdings Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2023
CI
Sinco Pharma Taps Moore Advisory Services for Internal Control Review
MT
Sinco Pharmaceuticals Co-CEO Resigns; Shares Slip 3%
MT
Sinco Pharmaceuticals Holdings Limited Announces Final Dividend for the Year Ended 31 December 2022, Payable on June 15, 2023
CI
Sinco Pharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Sinco Pharmaceuticals Holdings Limited Announces Chief Executive Officer Changes
CI
Sinco Pharmaceuticals Holdings Limited Appoints Lei Shifeng as Executive Director, with Effect from 29 March 2023
CI
Sinco Pharmaceuticals Expects 50% Drop in 2022 Profit; Shares Slip 4%
MT
Sinco Pharmaceuticals Holdings Limited Provides Group Earnings Guidance for the Year Ended 31 December 2022
CI
Sinco Pharmaceuticals Holdings Limited completed the acquisition of Deyang Demei Medical Aesthetic Clinic from Jiang Biao, Jiang Min and Jiang Jun.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6833 Stock
  4. News Sinco Pharmaceuticals Holdings Limited